It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...

Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.

New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.

A small and financially opaque drug research nonprofit group based in Ohio has managed to get its research cited extensively ...

Telehealth provider Hims & Hers Health is defending its planned Super Bowl ad, which is styled as a political manifesto ...

The biotech industry’s DeepSeek moment came last fall.

A bill that would subject pharmacy benefit managers to licensing by the state Department of Insurance faces a hurdle: Gov. Newsom.

U.S. President Donald Trump’s threats to slap tariffs on medicines could rattle an industry that has become a cornerstone of ...

A quirk in the website OpenSecrets has given RFK Jr. a chance to misleadingly portray Sen. Bernie Sanders as receiving big ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...